Response of Ewing tumor cells to forced and activated p53 expression

Oncogene

Volumn 22, Issue 21, 2003, Pages 3193-3204

  Kovar, Heinrich ^a   Pospisilova, Sarka ^a   Jug, Gunhild ^a   Printz, Dieter ^a   Gadner, Helmut ^a  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

Apoptosis; Ewing's sarcoma; EWS FLI1; Irradiation; p53

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EWS FLI1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CLINICAL PATHWAY; CONTROLLED STUDY; DNA DAMAGE; EWING SARCOMA; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; X RAY ANALYSIS; BONE TUMOR; CELL CULTURE; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY; X RAY;

APOPTOSIS; BONE NEOPLASMS; DNA DAMAGE; GENES, P16; HUMANS; MUTATION; SARCOMA, EWING'S; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; X-RAYS;

EID: 0037945212     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206391     Document Type: Article

References (58)

1. Beltinger CP, White PS, Maris JM, Sulman EP, Jensen SJ, LePaslier D, Stallard BJ, Goeddel DV, de Sauvage FJ and Brodeur GM. (1996). Genomics, 35, 94-100.
2. Chen X, Ko LJ, Jayaraman L and Prives C. (1996). Genes Dev., 10, 2438-2451.
3. de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-Mindan FJ, Healey JH and Ladanyi M. (2000). Cancer, 89, 783-792.
4. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc Carel C, Triche TJ, Anrias A and Thomas G. (1994). N. Engl. J. Med., 331, 294-299.
5. Deneen B and Denny CT. (2001). Oncogene, 20, 6731-6741.
6. Di Como CJ and Prives C. (1998). Oncogene, 16, 2527-2539.
7. Durocher D and Jackson SP. (2001). Curr. Opin. Cell Biol., 13, 225-231.
8. Friedlander P, Haupt Y, Prives C and Oren M. (1996). Mol. Cell. Biol., 16, 4961-4971.
9. Gorgoulis VG, Zacharatos PV, Manolis E, Ikonomopoulos JA, Damalas A, Lamprinopoulos C, Rassidakis GZ, Zoumpourlis V, Kotsinas A, Rassidakis AN, Halazonetis TD and Kittas C. (1998). Br. J. Cancer, 77, 374-384.
10. Gottlieb TM and Oren M. (1996). Biochim. Biophys. Acta, 1287, 77-102.
11. Grenet J, Valentine V, Kitson J, Li H, Farrow SN and Kidd VJ. (1998). Genomics, 49, 385-393.
12. Guimaraes DP and Hainaut P. (2002). Biochimie, 84, 83-93.
13. Hadano S, Nasir J, Nichol K, Rasper DM, Vaillancourt JP, Sherer SW, Beatty BG, Ikeda JE, Nicholson DW and Hayden MR. (1999). Mamm. Genome, 10, 757-760.
14. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC and Montesano R. (1998). Nucleic Acids. Res., 26, 205-213.
15. Hamelin R, Zucman J, Melot T, Delattre O and Thomas G. (1994). Int. J. Cancer, 57, 336-340.
16. Hattinger CM, Rumpler S, Strehl S, Ambros IM, Zoubek A, Potschger U, Gadner H and Ambros PF. (1999). Genes Chromosomes Cancer, 24, 243-254.
17. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
18. Haupt Y, Rowan S and Oren M. (1995). Oncogene, 10, 1563-1571.
19. Hermeking H, Funk JO, Reichert M, Ellwart JW and Eick D. (1995). Oncogene, 11, 1409-1415.
20. Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D and Nakagawara A. (1999). Oncogene, 18, 1061-1066.
21. Kovar H. (1998). Curr. Opin. Oncol., 10, 334-342.
22. Kovar H, Aryee DN, Jug G, Henockl C, Schemper M, Delattre O, Thomas G and Gadner H. (1996). Cell Growth Differ., 7, 429-437.
23. Kovar H, Auinger A, Jug G, Aryee D, Zoubek A, Salzer-Kuntschik M and Gadner H. (1993a). Oncogene, 8, 2683-2690.
24. Kovar H, Auinger A, Jug G, Aryee D, Zoubek A, Salzer-Kuntschik M and Gadner H. (1993b). Oncogene, 8, 2683-2690.
25. Kovar H, Fallaux FJ, Pribill I, Jugovic D, Bartl S, Ambros PF, Aryee DN, Wiegant JC and Hoeben RC. (2000a). Cancer Res., 60, 1557-1560.
26. Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R and Gadner H. (1997). Oncogene, 15, 2225-2232.
27. Kovar H, Jug G, Printz D, Bartl S, Schmid G and Wesierska-Gadek J. (2000b). Oncogene, 19, 4096-4107.
28. Kubbutat MH, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
29. Ladanyi M, Lewis R, Jhanwar SC, Gerald W, Huvos AG and Healey JH. (1995). J. Pathol., 175, 211-217.
30. Lahti JM, Xiang J and Kidd VJ. (1995). Prog. Cell Cycle Res., 1, 329-338.
31. Lassus P, Ferlin M, Piette J and Hibner U. (1996). EMBO J., 15, 4566-4573.
32. Lessnick SL, Dacwag CS and Golub TR. (2002). Cancer Cell, 1, 393-401.
33. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC and Ito Y. (2002). Cell, 109, 113-124.
34. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
35. McKeon C, Thiele CJ, Ross RA, Kwan M, Triche TJ, Miser JS and Israel MA. (1988). Cancer Res., 48, 4307-4311.
36. Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP and Hall PA. (1995). J. Cell Sci., 108, 1843-1848.
37. Mukae N, Enari M, Sakahira H, Fukuda Y, Inazawa J, Toh H and Nagata S. (1998). Proc. Natl. Acad. Sci. USA, 95, 9123-9128.
38. O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace AJJ and Kohn KW. (1997). Cancer Res., 57, 4285-4300.
39. Ouchida M, Ohno T, Fujimura Y, Rao VN and Reddy ES. (1995). Oncogene, 11, 1049-1054.
40. Park DJ, Nakamura H, Chumakov AM, Said JW, Miller CW, Chen DL and Koeffler HP. (1994). Oncogene, 9, 1899-1906.
41. Pietenpol JA, Lengauer C, Jordan J, Kinzler KW and Vogelstein B. (1996). Proc. Natl. Acad. Sci. USA, 93, 8390-8394.
42. Qin XQ, Livingston DM, Kaelin WGJ and Adams PD. (1994). Proc. Natl. Acad. Sci. USA, 91, 10918-10922.
43. Renzing J and Lane DP. (1995). Oncogene, 10, 1865-1868.
44. Sanchez-Prieto R, de Alava E, Palomino T, Guinea J, Fernandez V, Cebrian S, LLeonart M, Cabello P, Martin P, San Roman C, Bornstein R, Pardo J, Martinez A, Diaz-Espada F, Barrios Y and Cajal S. (1999). Nat. Med., 5, 1076-1079.
45. Sollazzo MR, Benassi MS, Magagnoli G, Gamberi G, Molendini L, Ragazzini P, Merli M, Ferrari C, Balladelli A and Picci P. (1999). Tumorigenesis, 85, 167-173.
46. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. (1998). EMBO J., 17, 5001-5014.
47. Tanaka K, Iwakuma T, Harimaya K, Sato H and Iwamoto Y. (1997). J. Clin. Invest., 99, 239-247.
48. Thomas M, Pim D and Banks L. (1999). Oncogene, 18, 7690-7700.
49. Toretsky JA, Connell Y, Neckers L and Bhat NK. (1997). J. Neurooncol., 31, 9-16.
50. Vecchio G, Cavazzana AO, Triche TJ, Ron D, Reynolds CP and Eva A. (1989). Oncogene, 4, 897-900.
51. Wagner AJ, Kokontis JM and Hay N. (1994). Genes Dev., 8, 2817-2830.
52. Wei G, Antonescu CR, de Alava E, Leung D, Huvos AG, Meyers PA, Healey JH and Ladanyi M. (2000). Cancer, 89, 793-799.
53. Woo RA, Jack MT, Xu Y, Burma S, Chen DJ and Lee PW. (2002). EMBO J., 21, 3000-3008.
54. Wu X and Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
55. Yonish-Rouach E, Borde J, Gotteland M, Mishal Z, Viron A and May E. (1994). Cell Death Differ., 1, 39-47.
56. Zhang Y, Xiong Y and Yarbrough WG. (1998). Cell, 92, 725-734.
57. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc Carel C et al. (1993). EMBO J., 12, 4481-4487.
58. Zucman-Rossi J, Legoix P, Victor JM, Lopez B and Thomas G. (1998). Proc. Natl. Acad Sci. USA, 95, 11786-11791.